Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 2
2012 3
2013 2
2014 8
2015 6
2016 3
2017 1
2018 3
2019 3
2020 2
2021 7
2022 6
2023 6
2024 4
2025 18
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Emerging Therapeutic Approaches for Anemia in Myelofibrosis.
Chifotides HT, Duminuco A, Torre E, Vetro C, Harrington P, Palumbo GA, Bose P. Chifotides HT, et al. Among authors: vetro c. Curr Hematol Malig Rep. 2025 May 3;20(1):7. doi: 10.1007/s11899-025-00751-4. Curr Hematol Malig Rep. 2025. PMID: 40317385 Review.
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape.
Duminuco A, Harrington P, Del Fabro V, Scalisi E, Santuccio G, Santisi A, Sbriglione A, Garibaldi B, Markovic U, Di Raimondo F, Palumbo GA, Pugliese N, Vetro C. Duminuco A, et al. Among authors: vetro c. Pharmaceuticals (Basel). 2025 Aug 16;18(8):1212. doi: 10.3390/ph18081212. Pharmaceuticals (Basel). 2025. PMID: 40872603 Free PMC article. Review.
VEXAS-like syndrome: a potential new entity?
Duminuco A, Vetro C, Markovic U, Di Raimondo F, Palumbo GAM. Duminuco A, et al. Among authors: vetro c. Ann Hematol. 2022 May;101(5):1125-1128. doi: 10.1007/s00277-022-04818-7. Epub 2022 Mar 22. Ann Hematol. 2022. PMID: 35318504 No abstract available.
Immunological dysregulation in multiple myeloma microenvironment.
Romano A, Conticello C, Cavalli M, Vetro C, La Fauci A, Parrinello NL, Di Raimondo F. Romano A, et al. Among authors: vetro c. Biomed Res Int. 2014;2014:198539. doi: 10.1155/2014/198539. Epub 2014 Jun 11. Biomed Res Int. 2014. PMID: 25013764 Free PMC article. Review.
Immunological deregulation in classic hodgkin lymphoma.
Romano A, Vetro C, Caocci G, Greco M, Parrinello NL, Di Raimondo F, La Nasa G. Romano A, et al. Among authors: vetro c. Mediterr J Hematol Infect Dis. 2014 Jun 1;6(1):e2014039. doi: 10.4084/MJHID.2014.039. eCollection 2014. Mediterr J Hematol Infect Dis. 2014. PMID: 24959336 Free PMC article. Review.
Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents.
Marconi G, Petracci E, Lanzarone G, Vetro C, Martelli MP, Papayannidis C, Audisio E, Minetto P, Riva C, Guolo F, Martini G, Zappasodi P, Vincenzo F, Gigli F, Griguolo D, Rondoni M, Ciotti G, Borlenghi E, Ciccone N, Palumbo FE, Nanni J, Mattei D, Bernardi M, Cignetti A, Zingaretti C, Vertogen B, Cerchione C, Lanza F, Cilloni D, Brunetti L, Palmieri R, Curti A, Giannini MB, Todisco E; AVALON research group; Fracchiolla N, Martinelli G. Marconi G, et al. Among authors: vetro c. Am J Hematol. 2025 Apr;100(4):708-711. doi: 10.1002/ajh.27591. Epub 2025 Jan 20. Am J Hematol. 2025. PMID: 39831709 Free PMC article.
Rare gastrointestinal lymphomas: The endoscopic investigation.
Vetro C, Bonanno G, Giulietti G, Romano A, Conticello C, Chiarenza A, Spina P, Coppolino F, Cunsolo R, Raimondo FD. Vetro C, et al. World J Gastrointest Endosc. 2015 Aug 10;7(10):928-49. doi: 10.4253/wjge.v7.i10.928. World J Gastrointest Endosc. 2015. PMID: 26265987 Free PMC article. Review.
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
Todisco E, Papayannidis C, Fracchiolla N, Petracci E, Zingaretti C, Vetro C, Martelli MP, Zappasodi P, Di Renzo N, Gallo S, Audisio E, Griguolo D, Cerchione C, Selleri C, Mattei D, Bernardi M, Fumagalli M, Rizzuto G, Facchini L, Basilico CM, Manfra I, Borlenghi E, Cairoli R, Salutari P, Gottardi M, Molteni A, Martini V, Lunghi M, Fianchi L, Cilloni D, Lanza F, Abruzzese E, Cascavilla N, Rivellini F, Ferrara F, Maurillo L, Nanni J, Romano A, Cardinali V, Gigli F, Roncoroni E, Federico V, Marconi G, Volpi R, Sciumè M, Tarella C, Rossi G, Martinelli G; AVALON Cooperative Group. Todisco E, et al. Among authors: vetro c. Cancer. 2023 Apr 1;129(7):992-1004. doi: 10.1002/cncr.34608. Epub 2023 Jan 24. Cancer. 2023. PMID: 36692409 Free article.
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial.
Russo D, Polverelli N, Bernardi S, Santarone S, Farina M, Borlenghi E, Onida F, Castagna L, Bramanti S, Carella AM, Sorasio R, Martino M, Alati C, Olivieri A, Beltrami G, Curti A, Vetro C, Leotta S, Mancini V, Terruzzi E, Bernardi M, Galieni P, Musto P, Cerretti R, Giaccone L, Skert C, Radici V, Vezzoli M, Calza S, Leoni A, Garuffo L, Bonvicini C, Pellizzeri S, Malagola M, Ciceri F. Russo D, et al. Among authors: vetro c. Lancet Haematol. 2024 Nov;11(11):e830-e838. doi: 10.1016/S2352-3026(24)00241-2. Epub 2024 Sep 20. Lancet Haematol. 2024. PMID: 39312920 Clinical Trial.
68 results